Ignite Creation Date:
2024-05-06 @ 3:03 PM
Last Modification Date:
2024-10-26 @ 1:41 PM
Study NCT ID:
NCT04501198
Status:
UNKNOWN
Last Update Posted:
2020-09-16
First Post:
2020-07-23
Brief Title:
Moxibustion Combined With Characteristic Lifestyle Intervention of Traditional Chinese Medicine in the Treatment of Abdominal Obesity A Study Protocol for a Randomized Controlled Trial
Sponsor:
Hubei Hospital of Traditional Chinese Medicine
Organization:
Hubei Hospital of Traditional Chinese Medicine
Study Overview
Official Title:
Moxibustion Combined With Characteristic Lifestyle Intervention of Traditional Chinese Medicine in the Treatment of Abdominal Obesity A Study Protocol for a Randomized Controlled Trial
Status:
UNKNOWN
Status Verified Date:
2020-09
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will investigate whether the combination of moxibustion and characteristic lifestyle intervention of TCM can alleviate the clinical symptoms and improve quality of life and mental health in patients with abdominal obesity The results are expected to provide clinical evidence for the application of the combination of moxibustion and characteristic lifestyle intervention of TCM in patients with abdominal obesity
Detailed Description:
This study will be a randomized controlled trial conducted from January 2020 to January 2022 that includes 150 participants who have abdominal obesity and meet the eligibility criteria The participants will be randomly divided into 3 groups in a 221 allocation ratioThe intervention group will receive moxibustion combined with characteristic lifestyle intervention of TCMthe other group will receive moxibustion combined with lifestyle interventionthe control group will receive lifestyle intervention onlyEach treatment will last 12 weeks including 8 weeks of intervention period and 4 weeks of follow-up period The primary outcome is the waist circumferenceWCthe secondary outcomes include obesity-related indicatorsserum biochemical indexsblood pressure conversion score of constitution characteristics and measurement of the scaleAdverse events will be recorded during the intervention and follow-up period
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None